"Australian biotech Genetic Signatures’ (ASX:GSS) is now able to start selling its recently developed COVID-19 diagnostic kit, after it was approved for sale in Australia.The EasyScreen SARS-CoV-2 Detection Kit has been approved to be listed on the Australian Register of Therapeutic Goods (ARTG).
The company’s test is a lab-based test which Genetic Signatures CEO Dr John Melki told * last week the company was initially pitching to pathology and microbiology labs. Genetic Signatures has already had sales talks with major listed companies."
"Australian biotech Genetic Signatures’ (ASX:GSS) is now able to...
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
36.5¢ |
Change
0.000(0.00%) |
Mkt cap ! $82.90M | |||
| Open | High | Low | Value | Volume |
| 36.5¢ | 37.0¢ | 36.5¢ | $22.81K | 62.10K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 2882 | 36.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 38.0¢ | 3086 | 1 |
View Market Depth
| Last trade - 15.50pm 07/07/2025 (20 minute delay) ? |
| GSS (ASX) Chart |